Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
31681 | 805 | 505 | Q9BYF1(ACE2_HUMAN) | RecName: Full=Angiotensin-converting enzyme 2; EC=3.4.17.23 ;AltName: Full=Angiotensin-converting enzyme homolog ; Short=ACEH ;AltName: Full=Angiotensin-converting enzyme-related carboxypeptidase ; Short=ACE-related carboxypeptidase; EC=3.4.17.- ;AltName: Full=Metalloprotease MPROT15 ;Contains: RecName: Full=Processed angiotensin-converting enzyme 2 ;Flags: Precursor; |
QUERYSEQ |
MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTL PFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNK NSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVM GVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF |
805 | region | name | description |
1-17 | SIGNAL | ||
18-805 | CHAIN | /note="Angiotensin-converting enzyme 2" /id="PRO_0000028570" | |
18-708 | CHAIN | /note="Processed angiotensin-converting enzyme 2" /id="PRO_0000292268" | |
18-740 | TOPO_DOM | /note="Extracellular" | |
741-761 | TRANSMEM | /note="Helical" | |
762-805 | TOPO_DOM | /note="Cytoplasmic" | |
19-607 | DOMAIN | /note="Peptidase M2" | |
614-805 | DOMAIN | /note="Collectrin-like" | |
30-41 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
82-84 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
353-357 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
652-659 | REGION | /note="Essential for cleavage by ADAM17" | |
697-716 | REGION | /note="Essential for cleavage by TMPRSS11D and TMPRSS2" | |
772-805 | REGION | /note="Disordered" | |
785-805 | COMPBIAS | /note="Polar residues" | |
375-375 | ACT_SITE | /note="Proton acceptor" ECO:0000305|PubMed:14754895, ECO:0000305|PubMed:27217402" | |
505-505 | ACT_SITE | /note="Proton donor" ECO:0000305|PubMed:14754895" | |
169-169 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
273-273 | BINDING | /ligand="substrate" | |
345-346 | BINDING | /ligand="substrate" | |
374-374 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
378-378 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
402-402 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
477-477 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
481-481 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
515-515 | BINDING | /ligand="substrate" | |
1-805 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
805 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
7v61 | B | 100.0 | ACE2_HUMAN Angiotensin-converting enzyme 2 | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r42[2] | B | disordered segment of collectrin homology domain[6.. | A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 | |
1r42[2] | C | disordered segment of collectrin homology domain[2.. | A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 | |
1r42[2] | E | disordered segment of collectrin homology domain[1.. | A | 100.0 /100.0 |
3 /3 |
angiotensin I converting enzyme 2 | |
3kbh[4] | B | SPIKE_CVHNL Spike glycoprotein[110 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6acg[4] | C | SPIKE_CVHSA Spike glycoprotein[1057 aa] | D | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[12] | A | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | B | 100.0 /100.0 |
24 /24 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8i93[2] | B | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[2] | B | SPIKE_SARS2 Spike glycoprotein[643 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a94[184] | A | SPIKE_SARS2 Spike glycoprotein[1080 aa] | D | 100.0 /100.0 |
15 /15 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dwx[11] | E | SPIKE_SARS2 Spike glycoprotein[1007 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xob[2] | A | SPIKE_SARS2 Spike glycoprotein[1026 aa] | E | 100.0 /84.3 |
1 /1 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
7bh9[1] | B | SPIKE_SARS2 Spike protein S1[144 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ddp[3] | B | A0A6G6A1M4_9BETC Spike protein S1[194 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7e7e[2] | B | h11B11-Fab[208 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7e7e[1] | C | h11B11-Fab[210 aa] | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7e7e[1] | F | h11B11-Fab[210 aa] | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7t9l[49] | A | SPIKE_SARS2 Spike glycoprotein[201 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7wk6[26] | A | SPIKE_SARS2 Spike glycoprotein[194 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7y75[8] | C | SPIKE_SARS2 Spike protein S1[198 aa] | B | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | C | 3E8[223 aa] | B | 100.0 /100.0 |
12 /12 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | D | 3E8[214 aa] | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xbf[5] | B | RshSTT182/200 coronavirus receptor binding domain .. | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7y75[14] | A | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3[5.. | B | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8b9p[2] | C | ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR.. | A | 100.0 /100.0 |
34 /34 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bfw[4] | B | ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bn1[2] | D | ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8e7m[1] | B | 05B04 Heavy Chain[218 aa] | A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8e7m[1] | C | 05B04 Light Chain[214 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8fxb[1] | D | SPIKE_SARS2 Spike protein S1[162 aa] | C | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8i9e[2] | B | SPIKE_SARS2 Spike protein S1[167 aa] | A | 100.0 /100.0 |
13 /13 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8toq[1] | B | Peptide 1[13 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tor[4] | B | Peptide 2[15 aa] | A | 100.0 /100.0 |
25 /25 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | B | Peptide 6[12 aa] | A | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8we4[1] | C | S304 Fab Heavy Chain[118 aa] | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8wlz[2] | A | U5WI05_SARS A0A346FJN8_BPT6 Spike glycoprotein,Fibritin[1068 aa] | D | 100.0 /100.0 |
22 /22 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8xnf[4] | B | SPIKE_SARS2 Spike glycoprotein[1001 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6vw1[16] | C | SPIKE_CVHSA SPIKE_SARS2 SPIKE_CVHSA SARS-CoV-2 chimeric RBD[193 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8uzf[2] | C | Receptor binding domain[188 aa] | A | 58.8 /95.8 |
17 /17 |
Angiotensin-converting enzyme 2 | |
7drv[3] | B | A0A6B9WHD3_SARS Spike glycoprotein[195 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7p8i[4] | B | A0A6B9WHD3_SARS Spike glycoprotein[193 aa] | A | 100.0 /100.0 |
13 /13 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7fc3[1] | A | SPIKE_CVHNL Spike protein S1[131 aa] | B | 87.5 /87.4 |
16 /16 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
2ajf[18] | C | SPIKE_CVHSA SARS-coronavirus spike protein[174 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
7wsf[3] | B | SPIKE_SARS Spike protein S1[186 aa] | A | 80.0 /83.4 |
20 /20 |
A0A452CBT6_BALAS Angiotensin-converting enzyme | |
6lzg[65] | B | SPIKE_SARS2 Spike protein S1[195 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[33] | C | SPIKE_SARS2 Spike protein S1[183 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8aqt[1] | B | SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[193 aa] | A | 42.9 /84.5 |
7 /7 |
ACE2_MOUSE GCAM_MOUSE Processed angiotensin-converting enzyme 2,Ig gamma.. | |
8u0t[1] | B | PRD-0038[174 aa] | A | 56.2 /79.7 |
16 /16 |
A0A0N7IQX6_RHIAY Angiotensin-converting enzyme | |
8hxk[1] | B | A0A7D6P0R3_9BETC Spike glycoprotein[676 aa] | A | 78.9 /79.6 |
19 /19 |
A0A7D7J6S6_RHIAI Angiotensin-converting enzyme | |
8k4u[1] | A | BtKY72[184 aa] | B | 70.6 /79.3 |
17 /17 |
ACE2 | |
7wpz[1] | B | A0A1W6ASU7_9NIDO Spike glycoprotein[192 aa] | A | 64.3 /78.5 |
14 /14 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7wpo[1] | B | U5NJG5_MERS Spike glycoprotein[187 aa] | A | 61.5 /78.2 |
13 /13 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r42[737] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 | |
1r42[170] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 | |
3kbh[144] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a91[57] | D |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a91[8] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7edj[27] | GB |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
D | 100.0 /100.0 |
2 /2 |
Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7efp[2] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /99.8 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7f5r[3] | N |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 66.7 /84.1 |
3 /3 |
mink ACE2 | |
7vx4[2] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wpo[4] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 25.0 /78.2 |
4 /4 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7wpo[2] | J |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 80.0 /78.2 |
5 /5 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7xid[2] | KB |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8hxk[1] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 50.0 /79.6 |
4 /4 |
A0A7D7J6S6_RHIAI Angiotensin-converting enzyme | |
8p2x[8] | K |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p2y[6] | N |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p30[2] | U |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8u0t[1] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /79.7 |
1 /1 |
A0A0N7IQX6_RHIAY Angiotensin-converting enzyme | |
9fmm[2] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
1r4l[1] | J |
XX5
(S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO-BENZYL)-3H-I.. |
A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
3d0g[6] | E |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
A | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[3] | I |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
B | 100.0 /98.5 |
1 /1 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[3] | J |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8p2x[8] | J |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[14 atoms.. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
6m18[6] | W |
3PH
1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE[48 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8b9p[2] | E |
LFI
1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-.. |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bfw[6] | E |
LFI
1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-.. |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
9fmm[2] | C |
A1IDX
(2~{S})-2-[[(2~{S})-3-[3-[(3-chloranyl-5-fluoranyl.. |
A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r42[62] | I |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
angiotensin I converting enzyme 2 | |
7l0n[1] | FB |
CL
CHLORIDE ION[1 atoms] |
I | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[2] | GB |
CL
CHLORIDE ION[1 atoms] |
I | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | AB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | CB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | DB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | EB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[2] | XA |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7tn0[3] | DA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | Q |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | CA |
CL
CHLORIDE ION[1 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | Y |
CL
CHLORIDE ION[1 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7whh[7] | E |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8df5[1] | AC |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | SA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | TA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[3] | VA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[1] | JB |
CL
CHLORIDE ION[1 atoms] |
F | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[1] | LB |
CL
CHLORIDE ION[1 atoms] |
F | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
9fmm[1] | L |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
1r42[60] | J |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
angiotensin I converting enzyme 2 | |
2ajf[183] | J |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
7pki[5] | N |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8aqs[1] | I |
ZN
ZINC ION[1 atoms] |
B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bn1[1] | F |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8ify[1] | TA |
ZN
ZINC ION[1 atoms] |
E | 100.0 /82.4 |
3 /3 |
A0A6J0Z472_ODOVR Angiotensin-converting enzyme | |
8ifz[1] | H |
ZN
ZINC ION[1 atoms] |
B | 66.7 /82.4 |
3 /3 |
A0A6J0Z472_ODOVR Angiotensin-converting enzyme | |
7l0n[1] | BB |
NA
SODIUM ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | YA |
NA
SODIUM ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ufk[2] | Q |
NA
SODIUM ION[1 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8byj[1] | G |
NA
SODIUM ION[1 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
9fmm[2] | M |
NA
SODIUM ION[1 atoms] |
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | Z |
MG
MAGNESIUM ION[1 atoms] |
B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xby[1] | D |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
3 /3 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | E |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
3 /3 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | F |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
1 /1 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | G |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
5 /5 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | H |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
4 /4 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2ajf[25] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
6vw1[14] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7p8i[3] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7p8i[10] | G | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7p8i[1] | L | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7sn0[1] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | N | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xwa[2] | I | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p2y[4] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8wdr[2] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8wp8[1] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8y16[4] | H | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[223] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[17] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[23] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[12] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a91[44] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7c8k[41] | B | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 75.0 /79.5 |
4 /4 |
E2DHI3_RHIMR Angiotensin-converting enzyme | |
7ct5[10] | CA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ct5[4] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[5] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /98.8 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[2] | G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /98.8 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dwx[14] | O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dwx[4] | Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kj2[6] | Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kj2[6] | R | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kj2[6] | U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7p8i[2] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7sn0[1] | L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wbp[2] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wpo[2] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 25.0 /78.2 |
4 /4 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7xo6[8] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /84.3 |
3 /3 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
7y1y[24] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7y1y[24] | GA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8i93[2] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8i93[2] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6vw1[3] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[2] | H | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /98.8 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[3] | J | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | C | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[2] | E | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8iou[8] | N | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | D | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8jje[1] | F | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /99.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7lo4[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7wa3[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | B | 75.0 /84.1 |
4 /4 |
A0A7T0Q2W2_NEOVI Angiotensin-converting enzyme | |
7wpo[1] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 66.7 /78.2 |
3 /3 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7yhw[2] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8e7m[1] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8e7m[1] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8h5c[1] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8tor[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8wdy[5] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | H | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | I | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | O | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | B | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ufk[2] | I | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8vqr[1] | H | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /95.8 |
3 /3 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
8y6a[1] | E | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7whh[1] | C | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7xb1[1] | D | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xwa[1] | J | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8if2[1] | D | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8p2x[4] | E | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
12 /12 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7dmu[1] | E | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8jje[1] | C | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /99.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7f5r[1] | H | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 75.0 /84.1 |
4 /4 |
mink ACE2 | |
7fc3[1] | C | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | B | 100.0 /87.4 |
4 /4 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
8t23[1] | D | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 50.0 /84.2 |
6 /6 |
A0A7T0Q2W2_NEOVI Angiotensin-converting enzyme | |
8tos[1] | C | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | D | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8vqr[1] | E | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 85.7 /96.1 |
7 /7 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
8vqr[1] | F | beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1.. | A | 100.0 /96.1 |
13 /13 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
8vqr[1] | J | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /95.8 |
15 /15 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
7wsk[1] | C | alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-be.. | A | 100.0 /85.2 |
4 /4 |
ACE2_PAGLA Processed angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
3d0g[3] | B | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | A | 100.0 /98.5 |
2 /2 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[3] | A | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3kbh[4] | E | ACE2_HUMAN Angiotensin-converting enzyme 2[593 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[18] | E | ACE2_HUMAN Angiotensin-converting enzyme 2[748 aa] | B | 100.0 /100.0 |
26 /26 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l7f[2] | C | ACE2_HUMAN Angiotensin-converting enzyme 2[711 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8bfw[2] | C | ACE2_HUMAN Processed angiotensin-converting enzyme 2[591 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8i93[2] | C | ACE2_HUMAN Angiotensin-converting enzyme 2[749 aa] | A | 100.0 /100.0 |
22 /22 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8p2x[8] | B | ACE2_HUMAN Processed angiotensin-converting enzyme 2[750 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6vw1[4] | P |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6vw1[12] | T |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6vw1[8] | U |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7lo4[4] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7lo4[2] | H |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7lo4[1] | I |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7p19[2] | H |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7u0n[1] | X |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ufk[3] | X |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ufl[3] | N |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8df5[2] | NA |
EDO
1,2-ETHANEDIOL[4 atoms] |
E | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[3] | OA |
EDO
1,2-ETHANEDIOL[4 atoms] |
E | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | PA |
EDO
1,2-ETHANEDIOL[4 atoms] |
E | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | QA |
EDO
1,2-ETHANEDIOL[4 atoms] |
E | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8uze[1] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
1 /1 |
Angiotensin-converting enzyme 2 | |
8uze[1] | O |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8uzf[2] | N |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
2 /2 |
Angiotensin-converting enzyme 2 | |
8vqr[1] | Q |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
3 /3 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
9fmm[1] | F |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
9fmm[1] | I |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
9fmm[2] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
9fmm[1] | U |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | PA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
I | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8asy[1] | R |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | K |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | L |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | T |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | C |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | E |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | K |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | M |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | N |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | O |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | P |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | Q |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | S |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | T |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | U |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8tor[2] | E |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tor[1] | G |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tor[2] | H |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | H |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | I |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | J |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[2] | P |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7pki[1] | H |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | I |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8jje[1] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /99.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |